EP 06 - The Future of Biologics: How Strategic CROs are Powering the Next Generation of Clinical Research

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/c7/a1/92/c7a1924b-5647-a572-6292-11553d4fe8b8/mza_10883373747415553384.jpg/600x600bb.jpg

THE BRIDGE with Pavlina Walter

Pavlina Walter

11 episodes

1 week ago

THE BRIDGE with Pavlina Walter explores how healthcare, technology, and clinical research come together to create real impact. From prevention-first innovation to AI you can trust, Pavlína connects investors, innovators, and policymakers in conversations that turn evidence into action. With a global perspective and a human focus, The Bridge is for leaders who believe progress in healthcare happens when science and technology serve people first.

Business

RSS

All content for THE BRIDGE with Pavlina Walter is the property of Pavlina Walter and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/44336137/44336137-1762759616954-182165d90164f.jpg

EP 06 - The Future of Biologics: How Strategic CROs are Powering the Next Generation of Clinical Research

THE BRIDGE with Pavlina Walter

32 minutes 1 second

1 month ago

EP 06 - The Future of Biologics: How Strategic CROs are Powering the Next Generation of Clinical Research

In this episode of The Bridge with Pavlina Walter, I was joined by my business partner, Dr. Peter M. Kovacs, and Jiri Raska, Chief Commercial Officer of Quinta Analytica, a Czech-based CRO shaping the future of biologics and clinical research.

We explore how strategic CRO partnerships accelerate innovation, from analytical chemistry to clinical trials.

Key themes:

• The rise of biologics and biosimilars in global healthcare.

• Why small biotech startups need integrated CRO partners.

• Regulatory realities and Europe’s path to faster approvals.

• How Central Europe is becoming a hub for biologics and ADCs.

• The human side of research: trust, communication, and collaboration.

Subscribe to The Bridge for more conversations connecting science, technology, and humanity.

Timecode:

00:00 Introduction to Jiri and Quinta Analytica

01:09 Jiri's Background and Passion for Chemistry

01:56 Transition to Business Development

03:43 Current Trends in Biologics and Biosimilars

05:57 Challenges and Opportunities in Clinical Studies

09:17 Supporting Small Biotech Startups

13:08 Customer Success Management

14:47 Expansion and Collaboration

16:43 Future of Personalized Medicine

19:26 Regulatory Challenges in Europe

23:58 Ostrava Subsidiary and Cross-Border Recruitment

27:00 Future Directions for Quinta Analytica

29:50 Jiri's Personal Career Aspirations

31:49 Conclusion and Final Thoughts

Links:

Pavlina Walter: https://www.linkedin.com/in/pavlinawalter/

Website: PavlinaWalter.com

Guests:

Jiri Raska: https://www.linkedin.com/in/jiri-raska-pharma/

Peter M. Kovacs: https://www.linkedin.com/in/petermkovacs/